You are here: Industry Insights > COVID-19

News List

Italy approves Pfizer and BioNTech’s Covid-19 vaccine for children Pharmaceutical-Technology
December 03, 2021
The Italian Medicines Agency (AIFA) has approved the use of the Pfizer and BioNTech Covid-19 vaccine, Comirnaty, for children aged five to 11 years.
All adults to be offered COVID-19 booster jabs by end of January 2022 PharmaTimes
December 02, 2021
The UK government has aimed to expand their COVID-19 vaccination programme, in accordance with guidance from the Joint Committee on Vaccination and Immunisation (JCVI)...
Up to 12 million people in England could face NHS waiting list crisis by 2025 PharmaTimes
December 02, 2021
Amid the COVID-19 pandemic, the NHS faces staff and hospital equipment shortages alongside the growing need to reduce the backlog in patient surgeries and treatments...
Delaying second dose of mRNA COVID-19 vaccine produces stronger immune response WorldPharmaNews
December 02, 2021
The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada...
FDA Advisory Committee Votes for Oral Antiviral Molnupiravir to Treat COVID-19 in High Risk Adults AmericanPharmaceuticalReview
December 02, 2021
Merck and Ridgeback Biotherapeutics provided the following statement at the conclusion of the FDA Antimicrobial Drugs Advisory Committee (AMDAC) regarding the Emergency Use Authorization (EUA) application for molnupiravir (MK-4482, EIDD-2801)...
CDC to Toughen COVID-19 Testing for International Travelers Drugs
December 02, 2021
As the world struggles with ways to stem the spread of the new omicron variant, the U.S. Centers of Disease Control and Prevention announced Tuesday that international travelers to the United States...
Pharma companies research whether vaccines need upgrade to fight Omicron variant CPhIonline
December 02, 2021
It could take pharmaceutical companies months to tweak their COVID-19 vaccines to provide sufficient protection against the Omicron variant of the coronavirus if it poses a risk of serious illness.
Smart Irrigation Market worth $2.3 billion by 2026 - Exclusive Report by MarketsandMarkets? prnewswire
December 02, 2021
According to the new research report, the "Smart Irrigation Market with COVID-19 Impact Analysis by System Type, Application (Greenhouses, Open-Fields, Residential, Golf Courses, Turf & Landscape)...
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001 AmericanPharmaceuticalReview
December 02, 2021
Valneva a specialty vaccine company, and IDT Biologika announced their collaboration for the production of Valneva’s inactivated COVID-19 vaccine candidate VLA2001. This follows last week’s announcement that Valneva signed an Advance Purchase Agreement...
Supply chain automation and traceability in lifesciences sector expresspharma
December 02, 2021
Global supply chains are complex and interconnected as manufacturers are dependent on other nations, especially developing countries, for procurement of active components, API or any other raw materials that go into the manufacturing of drugs...